scholarly article | Q13442814 |
P356 | DOI | 10.1017/S1092852900015443 |
P698 | PubMed publication ID | 17934380 |
P50 | author | Luis Augusto Rohde | Q45420577 |
P2093 | author name string | Cristian Patrick Zeni | |
Silza Tramontina | |||
Carla Ketzer de Souza | |||
Gabriel Ferreira Pheula | |||
P2860 | cites work | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder | Q22242775 |
A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
Juvenile bipolar disorder in Brazil: clinical and treatment findings. | Q35146068 | ||
Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. | Q35868432 | ||
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology | Q35963737 | ||
The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review | Q36015766 | ||
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. | Q36026701 | ||
Aripiprazole in children and adolescents: clinical experience | Q36256185 | ||
Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials | Q36827082 | ||
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors | Q44028935 | ||
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. | Q45206307 | ||
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 | ||
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children | Q46765699 | ||
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. | Q47208132 | ||
ADHD in Brazil: the DSM-IV criteria in a culturally different population | Q47429768 | ||
Risk of Substance Use Disorders in Adolescents With Bipolar Disorder | Q57400365 | ||
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD | Q73256558 | ||
P433 | issue | 10 | |
P921 | main subject | bipolar disorder | Q131755 |
attention | Q6501338 | ||
attention deficit hyperactivity disorder | Q181923 | ||
P304 | page(s) | 758-762 | |
P577 | publication date | 2007-10-01 | |
P1433 | published in | C N S Spectrums | Q15750260 |
P1476 | title | Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial | |
P478 | volume | 12 |
Q37653402 | A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. |
Q28073540 | Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis |
Q57612470 | Aripiprazole in Bipolar Disorder |
Q45990613 | Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. |
Q45484599 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. |
Q34199313 | Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula |
Q46637334 | Diminished 5-HT functioning in CBCL pediatric bipolar disorder-profiled ADHD patients versus normal ADHD: susceptibility to rapid tryptophan depletion influences reaction time performance |
Q37299210 | Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review |
Q34611306 | Focus on aripiprazole: a review of its use in child and adolescent psychiatry |
Q37557589 | Issues in the management of patients with complex attention-deficit hyperactivity disorder symptoms |
Q37498921 | Obesity, serious mental illness and antipsychotic drugs. |
Q46185243 | Pharmacotherapy in bipolar disorders during childhood and adolescence |
Q27027052 | Pharmacotherapy of bipolar disorder in children and adolescents: an update |
Q37742068 | Pharmacotherapy of bipolar disorder in children and adolescents: recent progress |
Q37768441 | Psychopharmacology of pediatric bipolar disorder. |
Q51054683 | Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study. |
Search more.